Lv1
10 积分 2024-10-09 加入
Risk of musculoskeletal disorders associated with Bruton's tyrosine kinase inhibitors: a disproportionality analysis of FAERS database and meta-analysis
1天前
待确认
Ocular disorders associated with PCSK9 inhibitors: A pharmacovigilance disproportionality analysis
5天前
已完结
The Effect of PCSK9 Monoclonal Antibodies on Platelet Reactivity and Cardiovascular Events in Patients Receiving Primary Percutaneous Coronary Intervention: A Propensity Score-Matched Analysis
1个月前
已完结
Predicting 28-day all-cause mortality in patients admitted to intensive care units with pre-existing chronic heart failure using the stress hyperglycemia ratio: a machine learning-driven retrospective cohort analysis
5个月前
已完结
Hyperglycaemic disorders associated with PCSK9 inhibitors: a real-world, pharmacovigilance study
7个月前
已完结
Impact of PCSK9 inhibitors in glycaemic control and new-onset diabetes
8个月前
已完结
Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial
8个月前
已完结
皖公网安备34019202002308
